Published in J Infect Dis on April 01, 1995
Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J Clin Microbiol (1998) 3.10
Identification of a Candidate Streptococcus pneumoniae core genome and regions of diversity correlated with invasive pneumococcal disease. Infect Immun (2006) 2.33
Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun (2001) 1.97
Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis (2008) 1.80
Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995. CMAJ (1998) 1.78
Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease. PLoS One (2010) 1.59
Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae. Infect Immun (2003) 1.54
The cps genes of Streptococcus suis serotypes 1, 2, and 9: development of rapid serotype-specific PCR assays. J Clin Microbiol (1999) 1.54
Molecular characterization of pneumococcal nasopharynx isolates collected from children during their first 2 years of life. J Clin Microbiol (1998) 1.40
Cancer vaccines and carbohydrate epitopes. Vaccine (2011) 1.40
B cell clones that sustain long-term plasmablast growth in T-independent extrafollicular antibody responses. Proc Natl Acad Sci U S A (2006) 1.38
Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol (2002) 1.36
Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B. Infect Immun (2008) 1.33
Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev (2012) 1.31
Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation. J Clin Microbiol (2003) 1.24
S. pneumoniae transmission according to inclusion in conjugate vaccines: Bayesian analysis of a longitudinal follow-up in schools. BMC Infect Dis (2006) 1.23
Upper respiratory tract microbial communities, acute otitis media pathogens, and antibiotic use in healthy and sick children. Appl Environ Microbiol (2012) 1.17
Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults. Clin Diagn Lab Immunol (2003) 1.12
Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94. Epidemiol Infect (1996) 1.02
Molecular analysis by pulsed-field gel electrophoresis and antibiogram of Streptococcus pneumoniae serotype 6B isolates from selected areas within the United States. J Clin Microbiol (1998) 1.01
Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention. Can J Infect Dis Med Microbiol (2009) 1.01
New pneumococcal vaccines for children. Arch Dis Child (2001) 0.99
Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice. Infect Immun (2001) 0.97
Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development. J Clin Microbiol (2006) 0.95
High rate of transmission of penicillin-resistant Streptococcus pneumoniae between parents and children. J Clin Microbiol (2002) 0.95
Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany. Eur J Clin Microbiol Infect Dis (2010) 0.94
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem. Antimicrob Agents Chemother (2008) 0.92
Nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children with acute respiratory tract infections in Thailand: a molecular epidemiological survey. J Clin Microbiol (1999) 0.90
Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany. Eur J Pediatr (2014) 0.89
Genetic relationship between Streptococcus pneumoniae isolates from nasopharyngeal and cerebrospinal fluid of two infants with Pneumococcal Meningitis. J Clin Microbiol (2003) 0.89
A new rat model of otitis media caused by Streptococcus pneumoniae: conditions and application in immunization protocols. Infect Immun (1999) 0.83
Polyvalent AIDS vaccines. Curr HIV Res (2010) 0.82
Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae and molecular characterization of multidrug-resistant serotype 19F, 6B, and 23F Pneumococci in northern Thailand. J Clin Microbiol (2003) 0.81
Capsule homology does not increase the frequency of transformation of linked penicillin binding proteins PBP 1a and PBP 2x in Streptococcus pneumoniae. Antimicrob Agents Chemother (2005) 0.79
Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression. Gastroenterol Hepatol (N Y) (2012) 0.79
Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection. Vaccine (2015) 0.77
Epidemiology, antibiotic susceptibility, and serotype distribution of Streptococcus pneumoniae associated with invasive pneumococcal disease in British Columbia - A call to strengthen public health pneumococcal immunization programs. Can J Infect Dis (2003) 0.76
Fatal infection in adults by pneumolysin & autolysin producing, non-vaccine serotype Streptococcus pneumonia. Indian J Med Res (2016) 0.75
Recognition of group D streptococcal species of human origin by biochemical and physiological tests. Appl Microbiol (1972) 13.09
Physiological differentiation of viridans streptococci. J Clin Microbiol (1977) 11.17
Presumptive identification of group A, B, and D streptococci. Appl Microbiol (1974) 8.23
Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun (1973) 7.01
Emergence of drug-resistant pneumococcal infections in the United States. JAMA (1994) 6.29
Comparison of several laboratory media for presumptive identification of enterococci and group D streptococci. Appl Microbiol (1973) 6.17
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
Presumptive identification of group D streptococci: the bile-esculin test. Appl Microbiol (1970) 6.00
Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol (1988) 5.71
The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med (1995) 5.18
Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med (1997) 4.84
Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis (1998) 4.55
Emergence of Buruli ulcer disease in the Daloa region of Cote d'Ivoire. Am J Trop Med Hyg (1995) 4.32
Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med (2000) 4.20
New insights to the MLL recombinome of acute leukemias. Leukemia (2009) 4.07
Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group. J Infect Dis (1991) 4.00
Nonhemolytic group B streptococci of human, bovine, and ichthyic origin. Infect Immun (1973) 3.81
Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA (2000) 3.42
Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med (1992) 3.39
Changing epidemiology of group A streptococcal infection in the USA. Lancet (1990) 3.35
Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA (1993) 3.31
The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis (1996) 3.26
Phylogenetic analysis of some Aerococcus-like organisms from clinical sources: description of Helcococcus kunzii gen. nov., sp. nov. Int J Syst Bacteriol (1993) 3.16
Evaluation of the Rapid Strep system for the identification of clinical isolates of Streptococcus species. J Clin Microbiol (1984) 3.16
Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis. Antimicrob Agents Chemother (1974) 3.06
Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations. Antimicrob Agents Chemother (Bethesda) (1970) 3.05
The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis (1992) 3.04
Evaluation of commercial latex agglutination reagents for grouping streptococci. J Clin Microbiol (1979) 2.95
Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis (1996) 2.85
Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med (1980) 2.85
Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis (1990) 2.80
Presumptive identification of group A, B, and D streptococci on agar plate media. J Clin Microbiol (1979) 2.72
Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality. Arch Intern Med (1994) 2.70
Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet (1991) 2.63
The MLL recombinome of acute leukemias in 2013. Leukemia (2013) 2.55
Presumptive identification of streptococci with a new test system. J Clin Microbiol (1982) 2.55
Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis (1996) 2.55
Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem? J Clin Microbiol (1989) 2.51
Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (2001) 2.40
Risk factors for transmission of Mycobacterium tuberculosis in a primary school outbreak: lack of racial difference in susceptibility to infection. Am J Epidemiol (1994) 2.34
Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun (1993) 2.32
Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med (1986) 2.26
Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group. J Clin Microbiol (1992) 2.23
Possible nosocomial transmission of group B streptococci in a newborn nursery. J Pediatr (1975) 2.21
Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr (1996) 2.17
Granulicatella and Abiotrophia species from human clinical specimens. J Clin Microbiol (2001) 2.14
Specificity study of kits for detection of group A streptococci directly from throat swabs. J Clin Microbiol (1987) 2.10
Rapid identification of enterococci. J Clin Microbiol (1983) 2.03
Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance. Pediatr Infect Dis J (1993) 1.95
Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob Agents Chemother (1990) 1.93
Phenotypic and genotypic characterization of atypical Lactococcus garvieae strains isolated from water buffalos with subclinical mastitis and confirmation of L. garvieae as a senior subjective synonym of Enterococcus seriolicida. Int J Syst Bacteriol (1996) 1.92
Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group. Clin Infect Dis (1995) 1.91
Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol (1999) 1.91
Differentiation of Lactococcus lactis and Lactococcus garvieae from humans by comparison of whole-cell protein patterns. J Clin Microbiol (1991) 1.91
The gram positive cocci. Hum Pathol (1976) 1.90
emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci. Microbiology (2000) 1.89
Neonatal enterococcal sepsis: case-control study and description of an outbreak. Pediatr Infect Dis J (1987) 1.89
Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife. Epidemiol Infect (2007) 1.87
A review of the microbiological techniques for the isolation and identification of streptococci. CRC Crit Rev Clin Lab Sci (1976) 1.84
Streptococcus faecium outbreak in a neonatal intensive care unit. J Clin Microbiol (1984) 1.81
Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group. JAMA (1996) 1.79
Correlation between phenotypic characteristics and DNA relatedness within Enterococcus faecium strains. J Clin Microbiol (1995) 1.79
Comparison of three commercial rapid identification systems for the unusual gram-positive cocci Dolosigranulum pigrum, Ignavigranum ruoffiae, and Facklamia species. J Clin Microbiol (2000) 1.78
Vancomycin-resistant Pediococcus acidilactici: nine cases of bacteremia. J Infect Dis (1990) 1.75
Antimicrobial susceptibility patterns of Streptococcus pneumoniae. Antimicrob Agents Chemother (1978) 1.75
An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med (1994) 1.73
Atmospheric growth requirements for Alloiococcus species and related gram-positive cocci. J Clin Microbiol (1996) 1.72
Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (2001) 1.69
Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J Infect Dis (2000) 1.69
Enterococcus raffinosus sp. nov., Enterococcus solitarius sp. nov. and Enterococcus pseudoavium sp. nov. FEMS Microbiol Lett (1989) 1.67
Nosocomial transmission of group B streptococci. Pediatrics (1976) 1.62
Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type. J Clin Microbiol (1998) 1.61
Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. Genes Dev (2000) 1.61
Physiological characterization of nutritionally variant streptococci. J Clin Microbiol (1979) 1.57
Antimicrobial susceptibilities of Lactococcus lactis and Lactococcus garvieae and a proposed method to discriminate between them. J Clin Microbiol (1996) 1.57
Streptococcal emm types associated with T-agglutination types and the use of conserved emm gene restriction fragment patterns for subtyping group A streptococci. J Med Microbiol (1998) 1.54
Outbreak of Legionnaires' disease among cruise ship passengers exposed to a contaminated whirlpool spa. Lancet (1996) 1.50
Evidence against person-to-person transmission of hantavirus to health care workers. Clin Infect Dis (1996) 1.50
The radiologic manifestations of Legionnaire's disease. The Ohio Community-Based Pneumonia Incidence Study Group. Chest (2000) 1.49
Rapid group A streptococcal antigen detection kit: effect on antimicrobial therapy for acute pharyngitis. Pediatrics (1988) 1.49
Aflatoxin levels in locally grown maize from Makueni District, Kenya. East Afr Med J (2008) 1.48
Capillary precipitin typing of Streptococcus pneumoniae. J Clin Microbiol (1978) 1.47
Risk factors for Nipah virus encephalitis in Bangladesh. Emerg Infect Dis (2008) 1.45